Open Access Green as soon as Postprint is submitted to ZB.
Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration.
Eur. J. Pharm. Biopharm. 77, 407-416 (2011)
Gold nanoparticles (GNP) provide many opportunities in imaging, diagnostics, and therapies of nanomedicine. Hence, their biokinetics in the body are prerequisites for specific tailoring of nanomedicinal applications and for a comprehensive risk assessment. We administered (198)Au-radio-labelled monodisperse, negatively charged GNP of five different sizes (1.4, 5, 18, 80, and 200 nm) and 2.8 nm GNP with opposite surface charges by intravenous injection into rats. After 24h, the biodistribution of the GNP was quantitatively measured by gamma-spectrometry. The size and surface charge of GNP strongly determine the biodistribution. Most GNP accumulated in the liver increased from 50% of 1.4 nm GNP to >99% of 200 nm GNP. In contrast, there was little size-dependent accumulation of 18-200 nm GNP in most other organs. However, for GNP between 1.4 nm and 5 nm, the accumulation increased sharply with decreasing size; i.e. a linear increase with the volumetric specific surface area. The differently charged 2.8 nm GNP led to significantly different accumulations in several organs. We conclude that the alterations of accumulation in the various organs and tissues, depending on GNP size and surface charge, are mediated by dynamic protein binding and exchange. A better understanding of these mechanisms will improve drug delivery and dose estimates used in risk assessment.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
4.304
1.920
387
410
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Gold nanoparticles; Intravenous injection; Female Wistar-Kyoto rat; In vivo biodistribution; Nanoparticle size and surface charge; Hepato-biliary and renal clearance
Language
english
Publication Year
2011
HGF-reported in Year
2011
ISSN (print) / ISBN
0939-6411
e-ISSN
0939-6411
Quellenangaben
Volume: 77,
Issue: 3,
Pages: 407-416
Publisher
Elsevier
Reviewing status
Peer reviewed
Institute(s)
Institute of Lung Health and Immunity (LHI)
POF-Topic(s)
30503 - Chronic Diseases of the Lung and Allergies
30503 - Chronic Diseases of the Lung and Allergies
Research field(s)
Lung Research
Lung Research
PSP Element(s)
G-505000-002
G-505000-005
G-505000-009
G-505000-005
G-505000-009
PubMed ID
21195759
WOS ID
WOS:000289380300011
Scopus ID
79952311136
Erfassungsdatum
2011-12-31